These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5565858)

  • 21. [Treatment of parkinsonism with L-dopa].
    Chouza C; Marín C; Romero S; Gomensoro JB
    Acta Neurol Latinoam; 1970; 16(1):170-83. PubMed ID: 5538052
    [No Abstract]   [Full Text] [Related]  

  • 22. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J
    J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of L-dopa on seborrhea of Parkinsonism.
    Appenzeller O; Harville D
    Lancet; 1970 Aug; 2(7667):311-2. PubMed ID: 4194387
    [No Abstract]   [Full Text] [Related]  

  • 24. L-dopa and parkinsonism.
    Okihiro MM
    Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R; Rahme M; Schott B
    J Med Lyon; 1971 Apr; 52(207):599-615. PubMed ID: 5136571
    [No Abstract]   [Full Text] [Related]  

  • 26. [Parkinsonism and L-dopa: our 1st results].
    Warot P; Petit H; Chevalier-Lefebvre J; Herbaut G
    Lille Med; 1971 May; 16(5):765-7. PubMed ID: 5115349
    [No Abstract]   [Full Text] [Related]  

  • 27. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.
    Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744
    [No Abstract]   [Full Text] [Related]  

  • 28. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
    Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT
    Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429
    [No Abstract]   [Full Text] [Related]  

  • 29. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I
    J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of Parkinsonism with L-dopa].
    Diaz Pérez G; Asenjo A; Chiorino R; Donoso P
    Neurocirugia; 1970; 28(1):17-23. PubMed ID: 5473365
    [No Abstract]   [Full Text] [Related]  

  • 31. [General intelligence of patients with parkinsonism during L-dopa medication (author's transl)].
    Jacobi P; Fischer PA; Schneider E
    Arch Psychiatr Nervenkr (1970); 1974; 218(2):125-40. PubMed ID: 4817897
    [No Abstract]   [Full Text] [Related]  

  • 32. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
    Donnelly EF; Chase TN
    Dis Nerv Syst; 1973 Feb; 34(2):119-23. PubMed ID: 4706860
    [No Abstract]   [Full Text] [Related]  

  • 33. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
    Buscaino GA; Campanella G; Zallone E
    Minerva Med; 1971 Oct; 62(82):3974-8. PubMed ID: 5125057
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 35. [Figure drawing test in Parkinsonic patients treated with L-dopa].
    Puca FM; Megna GF; Barbieri NF; Di Perri R
    Acta Neurol (Napoli); 1972; 27(4):395-402. PubMed ID: 4563704
    [No Abstract]   [Full Text] [Related]  

  • 36. [L-DOPA treatment of parkinsonism: analysis of the clinical course in follow-up cases].
    Ando K; Kono K; Sofue I
    Nihon Rinsho; 1973 Oct; 31(10):2980-6. PubMed ID: 4798116
    [No Abstract]   [Full Text] [Related]  

  • 37. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 38. [L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism].
    Fujimori N; Kito S; Yamamoto M; Itoga E; Kosaka K
    Nihon Rinsho; 1974 Mar; 32(3):579-86. PubMed ID: 4859014
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of severe parkinsonism with L-dopa.
    Reef HE; Joffe R; Milletz H
    S Afr Med J; 1971 May; 45(18):504-7. PubMed ID: 4941208
    [No Abstract]   [Full Text] [Related]  

  • 40. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.